Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D): Identifying the "Responder"

NCT00745004 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT00745004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00745004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D): Identifying the "Responder"
Lead sponsor
University of Nottingham
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
July 31, 2011
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome with diarrhoea